Operating income before deduction of amortization: acceleratediagnostics.com (AXDX)
EBITDA allows for an assessment of the scale of Accelerate Diagnostics (AXDX) through laboratory partnerships and M&A activity. The supply of infection identification systems to hospitals generates steady revenue. However, automation adoption rates and sales cycles necessitate strict expense control. The current level of reflects the magnitude of operating profit, demonstrating the company's cash accumulation speed and market positioning.
Accelerate Diagnostics, Inc. (AXDX) - metric breakdowns and financial figures
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
Total Debt to Capital Accelerate Diagnostics|AXDX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Accelerate Diagnostics Inc.|AXDX - Company Aggregate Debts|Debt to Book Value Accelerate Diagnostics|AXDX - Company Long-Term Debts|Short-Term Debt Accelerate Diagnostics|Quick Liquidity acceleratediagnostics.com
- company profitability and valuation multiples indicators:
AXDX - Net Profit|Expected Net Profit Accelerate Diagnostics|AXDX - Price to Earnings Ratio|Future Price to Earnings Multiple acceleratediagnostics.com|AXDX - PEG Multiple|EV/EBITDA Multiple Accelerate Diagnostics|AXDX - Operating profit before deduction of amortization|Earnings per share for the last four quarters Accelerate Diagnostics|AXDX - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months acceleratediagnostics.com|AXDX - Net earnings per share growth this year|Expected earnings per share trend next year Accelerate Diagnostics
Summary company analytics:AXDX - Accelerate Diagnostics Inc
Accelerate Diagnostics (AXDX) revenues depend directly on the expansion of Pheno systems and regular sepsis test sales within hospitals. By analyzing actual operating profit, an investor can observe the daily cash flow from core business operations, which allows for the identification of systemic crises or growth points while assessing the risk of capital freeze when purchasing the asset at local lows.
Who Accelerate Diagnostics competes with
Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Operating profit EBITDA SHC|Operating profit EBITDA quidel.com (QDEL)|Operating profit EBITDA OPK (OPKO Health)|CDNA - Operating profit before deduction of amortization|Maravai LifeSciences Corp - Operating profit EBITDA|Fulgent (FLGT) - Operating profit before deduction of amortization|LAB: Operating profit EBITDA|Profit before interest, taxes and amortization cytekbio.com (CTKB)|Profit before payment of interest, taxes and amortization OraSure|Profit before payment of interest, taxes and amortization XGN|Operating profit EBITDA MDXH|LUCD - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Prenetics PRE|Income before deduction of interest, taxes and amortization IMDX|Trinity Biotech Corp - Operating profit EBITDA|PRPH - Operating profit EBITDA|AIMD (Ainos Corp) - Operating profit before deduction of amortization|CODX: Company profit before taxes, interest and amortization|HSCS (Heart Test Laboratories) - Operating profit EBITDA|Profit before interest, taxes and amortization biomerica.com BMRA|Operating profit before deduction of amortization CDIO (Cardio Diagnostics)|ONCO (Onconetix Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA VRAX (Virax Biolabs Group Ltd)|BJDX: Operating profit before amortization|Aspira Women's Health - Operating profit EBITDA|Operating income before deduction of amortization Centogene CNTG|ENZ: Operating profit EBITDA|Fresh2 Group (FRES) - Operating profit EBITDA|GENE (Genetic Technologies Ltd) - Operating profit EBITDA|ME - Operating profit before depreciation charges|Profit before payment of interest, taxes and amortization Psychemedics (PMD)
